Panelists discuss how current risk stratification systems, particularly the European Leukemia Net 2022 classification for intensive therapy and the 2024 classification for lower intensity treatments, ...
May 1, 2008 — New details of differences among patients with cytogenetically normal acute myeloid leukemia (AML), which appear to affect both clinical and treatment outcome, are described in 2 papers ...
•Genomic characterization determines diagnosis, classification, and prognostication of the myeloid malignancies myelodysplastic syndrome (MDS) and AML. •Recognizing genetic lesions as invariable ...
Comparison of blast clearance in peripheral blood and day 14 bone marrow biopsy for evaluation of disease response after 7+3 induction in acute myeloid leukemia (AML). This is an ASCO Meeting Abstract ...
Results from a study conducted by St. Jude Children's Research Hospital and the Munich Leukemia Laboratory were presented today as a late-breaking abstract at the American Society of Hematology annual ...
Acute Myeloid Leukemia (AML) affects both adults and children and is molecularly heterogeneous. Based on high prevalence of mutations in a number of genes including DNMT3A, IDH1, and IDH, targeted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback